Stocks and Investing
Stocks and Investing
Thu, May 16, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mark Massaro Maintained (BNGO) at Strong Buy with Decreased Target to $2 on, May 16th, 2024
Mark Massaro of BTIG, Maintained "Bionano Genomics, Inc." (BNGO) at Strong Buy with Decreased Target from $3 to $2 on, May 16th, 2024.
Mark has made no other calls on BNGO in the last 4 months.
There is 1 other peer that has a rating on BNGO. Out of the 1 peers that are also analyzing BNGO, 0 agree with Mark's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mark
- Sung Ji Nam of "Scotiabank" Maintained at Buy with Decreased Target to $6 on, Thursday, March 7th, 2024
Contributing Sources